Agendia Receives Fifth FDA Clearance For Industry Leading MammaPrint(R) Assay

[News]

Agendia, a world leader in molecular cancer diagnostics, announced that the company has received its fifth U.S. Food and Drug Administration (FDA) clearance for MammaPrint(R), its widely used breast cancer recurrence assay...

More... (http://www.medicalnewstoday.com/articles/217376.php)